Plasma lactate and severity of illness for acute pulmonary embolism: A Bayesian probability model
Open Access
- 8 April 2026
- journal article
- Published by Wolters Kluwer Health in International Journal of Critical Illness and Injury Science
- Vol. 16 (2) , 67-71
Abstract
Background: Plasma lactate >2 mmol/L has been associated with increased mortality in acute pulmonary embolism (PE), even among hemodynamically stable patients. Despite strong evidence, lactate remains underutilized in risk stratification tools such as the simplified PE Severity Index (sPESI). To assess the incremental prognostic value of plasma lactate when integrated into a Bayesian probability model for Pulmonary Embolism. Methods: Pretest probabilities were defined by SI and sPESI. Sensitivity and specificity for plasma lactate >2 mmol/L were derived from prior meta-analyses and validated multicenter datasets. Likelihood ratios were applied within a Bayesian nomogram to estimate posttest probabilities. Diagnostic efficiency was evaluated using Bayesian Diagnostic Gain (BDG) and Bayesian Number Needed to Diagnose (BNND). Results: Thirty-day mortality for SI >1 was 24.1% versus 10.7% for low-risk SI and 10.7% versus 1.5% for sPESI. Lactate >2 mmol/L yielded 82.4% sensitivity (95% confidence interval [CI]: 56.8–95.3) and 73.5% specificity (95% CI: 71.8–74.4). Integrating lactate into the SI model produced an Absolute Diagnostic Gain (ADG) of 25.9% (BNND = 4), outperforming the sPESI model (ADG: 16.3%, BNND = 6). Conclusions: Bayesian integration of plasma lactate with the SI enhances prognostic accuracy and produces superior diagnostic gains compared with sPESI-based models. This supports a probabilistic, physiology-driven approach to PE risk stratification.Keywords
This publication has 13 references indexed in Scilit:
- Association between sPESI score and 90-day hospital readmissions in patients with acute pulmonary embolismEuropean Journal of Internal Medicine, 2025
- Haemodynamic Consequences of Acute Pulmonary Embolism Predict Risk of CTPA-Related Acute Kidney InjuryESC Heart Failure, 2025
- Relationship Between the Lactate-to-Albumin Ratio and 28-Day Overall Mortality in Critically Ill Patients with Pulmonary Embolism: A Retrospective Analysis of the MIMIC-IV DatabaseClinical and Applied Thrombosis/Hemostasis, 2025
- Venous lactate as a tool for the Risk-Stratification of patients with acute pulmonary embolism: A retrospective cohort studyClinical Biochemistry, 2025
- Association of Lactate with Risk of Cardiovascular Diseases: A Two-Sample Mendelian Randomization StudyVascular Health and Risk Management, 2024
- Characteristics and outcomes of cancer patients who develop pulmonary embolism: A cross‑sectional studyOncology Letters, 2022
- Venous lactate improves the prediction of in-hospital adverse outcomes in normotensive pulmonary embolismEuropean Journal of Internal Medicine, 2021
- Venous lactate: The new “magic marker” for stratification in intermediate-risk pulmonary embolism?European Journal of Internal Medicine, 2021
- A Bayesian decision support sequential model for severity of illness predictors and intensive care admissions in pneumoniaBMC Medical Informatics and Decision Making, 2019
- Improved rule-out diagnostic gain with a combined aortic dissection detection risk score and D-dimer Bayesian decision support schemeJournal of Critical Care, 2017